2 Nov
Presentation for the Second Virtual Congress of General Practice and Family Medicine (2009) about self-learning and the Internet. Key questions are perseverance, asking good questions during the clinical encounter and do not use self-compassion as an excuse (“I have no time today”). Download presentation here.
31 Oct
Swine flu vaccination, better natural immunity than artificial one. Gripe A, mejor la enfermedad que la vacuna / Swine flu vaccination, better natural immunity than artificial one. Gérvas, J., Wright, J. [Notas clínicas]. Septiembre de 2009. Download English version here. Please may we have an RCT now?. Gérvas, J., Wright, J. BMJ 2009; 339: b4651. [...]
30 Oct
30 Oct
The severity of swine flu is generally very low but WHO (World Health Organization) papers and policy transmit the idea of: a/ swine flu is a terrible and dangerous disease, and b/ prevention and treatment of flu swine is justifiable, necessary and urgent. It looks like a “disease mongering” campaign by WHO. Disease mongering by [...]
30 Oct
Prevention might be seen as a simple activity. Prevention in some way might compensate the clinical duties of the general practitioner. But dealing with uncertainty is a question which also affects to prevention. Prevention should be part of the encounters in General Practice but only as a complement to clinical activities. Prevention is not central [...]
30 Oct
Many doctors allowed themselves to be exposed to drug promotion. These doctors may have become infected with bias without knowing it. These bias could determine actions that decrease patient and population health. In this paper we review the evidence about how to overcome the industrial influence. Physicians, the industry, and population health. Gérvas, J., Mansfield, [...]
6 May
The cerivastatin fatal rhabdomyolysis affair should be use as an example to stimulate reconsideration of the whole process of drug approval, marketing and use, as occurred after thalidomide was found to cause adverse effects to the foetus. It is not just a safety issue. Cerivastatin and fatal rhabdomyolysis: not just a safety issue. Gérvas, J., [...]
